Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vaginal birth after C-Section: is it as safe as a repeat C-Section?

NCT ID NCT05439733

Knowledge-focused Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study looks at women who have had one cesarean section and are now deciding how to give birth again: trying a vaginal delivery (TOLAC) or scheduling another C-section (ERCD). The goal is to compare the safety of both options for the baby and the mother. Researchers will follow a large group of women in France and collect information through questionnaires after delivery to see if TOLAC is as safe as ERCD.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Questionnaire completion
What this could lead to
If TOLAC is shown to be as safe as ERCD, more women might choose it, potentially reducing repeat surgeries and their long-term risks.
What could go wrong
This is an observational study, so it can't prove cause and effect. Results may be influenced by unmeasured factors, and individual risks vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

16,764 people

The number who actually took part.

Started

Jun 2023

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women age of 18 years or older

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women age of 18 years or older * Women admitted to the labour ward at gestational age ≥ 34 weeks * Women with a singleton pregnancy * Women with one previous caesarean delivery * Computer savvy-women Exclusion Criteria: Exclusion criteria : * Women who oppose to participation in the study * Age \< 18 years * Women admitted to the labour ward at gestational age \< 34 weeks * Women with multiple pregnancy * Women with more than one previous caesarean or more than one uterine scar * Women who do not understand the French language * Women under judicial protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Scarred uterus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Asherman syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Scarred uterus

Contacts and locations

Locations

  • Assistance Publique Hôpitaux Marseille

    Marseille, Bouches-du-rhône, 13354, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.